2009 was an incredible year for the dietary supplement industry.  While the rest of American business floundered amidst the depths of a recession, the dietary supplement business thrived.  Americans concerned about maintaining their good health stocked up on supplements by the shopping cartful. In a year when initial public offerings and acquisitions were almost unheard [...]

David Frum could have lowered his rhetorical blood pressure in his CNN.com guest commentary on the evils of dietary supplement marketing by reading the FTC regulations that go into effect on Tuesday. His column then would have begun: The party is over Dec. 1.

Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyperlinked line that warns consumers about the potential dangers of a drug.

On Nov. 12, drugmakers and search-engine advertising agencies participated in about 30 presentations before the FDA. The hearing room was so crowded that most people seeking an audience seat were turned away. What did the company executives say?

FDA Principal Deputy Commissioner Joshua M. Sharfstein, M.D. gave the keynote speech to the Council for Responsible Nutrition Conference yesterday. Dr. Sharfstein expressed a willingness to work with supplement industry members and received a warm welcome from industry members in return.

Responsible Nutrition at the Terranea Resort in Racho Palos Verdes, California. Speakers on the agenda included a variety of supplement industry heavyweights and important government regulators.